United States

Koninklijke Philips NV (PHG.AS)

PHG.AS on Amsterdam Stock Exchange

9:26am EDT
Change (% chg)

€-0.22 (-0.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for PHG.AS


Koninklijke Philips N.V. is a health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, and Lighting. The Company's Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected... (more)


Beta: 1.50
Market Cap(Mil.): €29,506.93
Shares Outstanding(Mil.): 929.65
Dividend: 0.80
Yield (%): 2.52


  PHG.AS Industry Sector
P/E (TTM): 28.75 44.54 17.29
EPS (TTM): 1.10 -- --
ROI: 5.08 7.70 -5.84
ROE: 8.51 12.65 -5.23

BRIEF-Philips acquires US-based Respirtech


May 22 2017

Philips CEO: uptake of connected care products progressing slowly

AMSTERDAM The adoption of connected technologies in healthcare remains limited and is progressing slowly, despite the promise they hold for cutting medical costs by preventing illness, the chief executive of Philips said on Wednesday.

May 17 2017

BRIEF-Koninklijke Philips to sell part of its stake in Philips Lighting

* Announces intended sale of part of its stake in Philips Lighting

Apr 25 2017

Philips core earnings up 18 pct despite soft sales growth

AMSTERDAM, April 24 Philips, the maker of medical devices and healthcare products, reported on Monday better than expected core earnings of 442 million euros ($480 million) for the first quarter, up 18 percent, despite weak sales growth.

Apr 24 2017

BRIEF-Philips Q1 net income jumps to 259 million euros

* Q1 net income amounted to EUR 259 million, compared to EUR 37 million in q1 2016

Apr 24 2017

BRIEF-Koninklijke Philips couples sustainability performance to interest rate of its new 1 billion euro revolving credit facility

* Signed an agreement with a consortium of sixteen banks for a new 1 billion euros ($1.07 billion) revolving credit facility

Apr 19 2017

BRIEF-Philips receives FDA clearance to market pathology solution in the U.S.

* Receives clearance from the U.S. Food and Drug Administration (FDA) to market Philips Intellisite pathology solution for primary diagnostic use in the U.S. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Apr 13 2017

BRIEF-Philips appoints Jasper Westerink as CEO Philips Africa

* Appointment of Jasper Westerink as chief executive officer (market leader) for Philips Africa based out of Johannesburg Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Apr 03 2017

BRIEF-Philips to acquire Australian pharmacy sleep services company

* Said on Monday it has signed an agreement to acquire Australian Pharmacy Sleep Services (APSS), a pharmacy sleep testing company

Mar 28 2017

BRIEF-Koninklijke Philips reports 15.5 pct stake in Corindus Vascular Robotics

* Koninklijke Philips N.V. Reports 15.5 percent stake in Corindus Vascular Robotics Inc, as of February 28, 2017 - sec filing

Mar 10 2017

More From Around the Web

Earnings vs. Estimates